Share on Facebook
Share on Twitter
Click to Open Quick Navigation
Search The Web
Science & Tech
Billionaires Set to Return NBA to Seattle - Without the Big Tax Bill
FDA Rejects Orexigen's New Diet Drug Over Heart Concerns
FDA Panel Backs Orexigen's Diet Pill
FDA Panel Votes Against Arena's Diet Drug
FDA to Review Arena's Diet Drug, Alkermes' Painkiller Addiction Med
Vivus Hammered After FDA Panel's 'No' Vote; Orexigen Down, Arena Up
FDA Advisory Panel Rejects Vivus Weight-Loss Drug Qnexa
Arena's Obesity Drug Shows Promise, Stock Moves Wildly
Weight-Loss-Drug Maker Vivus Soars on FDA Panel Review
Arena to License Weight-Loss Drug to Eisai in U.S.; Shares Spike
Recommended For You
Bernie Sanders ditches Trump administration's 'road show' North Korea briefing
Tad Cummins' wife: He told me he slept with teen student, asked for forgiveness
Texas House approves a bill targeting 'sanctuary cities'
Insurer Molina may drop Obamacare members in 2017
Ilie Nastase makes bold new racially charged comment about Serena Williams' unborn...
Thousands gather for funeral of FDNY firefighter killed in the line of duty
Trump goes on raging tweetstorm against Democrats over negotiations to avoid a gov...
Rep. Maxine Waters blasts Trump: 'You can't trust this president'
More to Explore
Set Your Location
City, State, or Zip
Change weather location
Sign In / Join